| Model Number |
FR995-23 |
| Medical Device Problem Codes |
Insufficient Device Problem Information (3190); Device Stenosis (4066); Intravalvular regurgitation (4068)
|
| Health Effect - Clinical Codes |
Aortic Valve Stenosis (1717); Aortic Valve Insufficiency/ Regurgitation (4450); Insufficient Information (4580)
|
| Date of Event |
09/25/2024
|
|
Type of Reportable Event
|
Serious Injury
|
|
Additional Manufacturer Narrative
|
|
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Event or Problem Description
|
|
Medtronic received information that 12 years and 11 months post implant of this 23mm aortic bioprosthetic valve, the patient is being evaluated for a transcatheter valve-in-valve replacement.The reason for evaluation was not reported.It was stated that heavy concentric calcification was noted in the sinotubular junction.No intervention or adverse patient effects were reported.Subsequently, 19 days later, a transcatheter valve was implanted valve-in-valve.The reason for intervention was not reported.No additional adverse patient effects were reported.
|
| |
|
Additional Manufacturer Narrative
|
|
Corrections: b2 - additional checkbox ticked b5 - further event information added h6 - ime, img, fdd codes replaced, imf code added.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Event or Problem Description
|
|
Medtronic received information which stated that the reason for intervention was reported as moderate to severe aortic regurgitation (ar) and aortic stenosis (as).No additional adverse patient effects were reported.
|
| |
|
Search Alerts/Recalls
|